Explore tweets tagged as #cmnd
$CMND CMND-100 announced today Phase I/IIa Data: The trial for Alcohol Use Disorder (AUD) is currently enrolling its third cohort as of mid-March 2026. Positive topline safety and tolerability results from the second cohort (March 2026) cleared the way for this higher-dose (80
0
1
1
$CMND $0.80 added casH/s $1.40 Banger PR just in 🗞️ 2M floater
0
0
0
$CMND 09:15 on Mar. 17 2026 Clearmind Medicine Announces Publication of Six Innovative Patents in Hong Kong for Next-Generation Psychedelic-Based Combination Therapies
0
0
0
⚡️News: $CMND 07:30 on Mar. 04 2026 Clearmind Medicine Moving Forward to the Next Stage of Its Clinical Trial Following Data and Safety Monitoring Board Approval
0
0
0
$CMND Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy
0
0
0
📊 Most Shorted Stocks (SI% of Float) 1. $JDZG - 1,326% 🔥 2. $PAVS - 522% 3. $AGPU - 281% 4. $UOKA - 278% 5. $CMND - 172% 6. $HUBC - 156% 7. $CISS - 132% 8. $ALBT - 119% ⚠️ >100% SI = extreme squeeze risk Follow @ShortSideIO 🎯
0
0
0
Continued: - $YYGH: +4.6% (RVOL 5.2, 3 alerts, $0.0459-$0.048) - $TPET: +3.2% (RVOL 1.9, 3 alerts, $1.24-$1.28) - $CMND: +3.1% (RVOL 163.7, 2 alerts, $0.6889-$0.7101)
1
0
0
$WKEY $LQDT $LICN $TRUG $IVAC $ZENA $CADL $HIMX $LNKS $JUNS $INVZ $SMXT $KEQU $SENS $AMPG $TNXP $KEQU $EUDA $FLGC $NTRP $GAMB $TC $DDI $TYGO $CMND $XGN $HCTI $FENG $NA $NOTE $SMLR $ZONE $INAQ $PLRZ $CTHR $CELH https://t.co/7MBknbV4zv
0
0
1
$CMND < $1 - Clearmind Medicine 🔹Announces Publication of Six Innovative Patents March 17, 2026 🔹In Hong Kong for Next-Generation Psychedelic-Based Combination Therapies 🔹The 6 patents protect formulations combining PEA with MDMA, LSD, ketamine, ibogaine, psilocybin, and
0
2
3
$CMND Rare to see these 1M floats sub $1 News yesterday, a sneeze of 1 more PR we could 3-4x
0
1
3
$CMND * patent6x pr🗞️ 1.40$ Cash/share but trading at .74$? dude lfg 🔥
0
3
3
$CMND Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy
0
0
0
$CMND 08:45 on Mar. 19 2026 Clearmind Medicine Reports Successful Ongoing Treatment of Participants at US Sites in its FDA-approved CMND-100 Phase I/IIa Clinical Trial for Alcohol Use Disorder
0
0
1
$CMND 07:30 on Mar. 04 2026 Clearmind Medicine Moving Forward to the Next Stage of Its Clinical Trial Following Data and Safety Monitoring Board Approval
0
0
1
$CMND [1.38$] [6.15%] [2026-03-17T00:00:00.000Z] Clearmind Medicine Announces Publication of Six Innovative Patents in Hong Kong for Next-Generation Psychedelic-Based Combination Therapies
0
0
0
Key levels being tested. $CMND $NTLX. Clearmind Medicine publishes six new patents in Hong Kong for next-gen psychedelic combos. A technical move. Scale in with caution. Manage risk.
0
0
0
$CMND +nan% today Clearmind Medicine Reports Successful Ongoing Treatment of Participants at US Sites in its FDA-approved CMND-100 Phase I/IIa Clinical Trial for Alcohol Use Disorder More Info: https://t.co/4vQ7YFCUUt
0
0
0
$CMND Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
1
0
1
$CMND Clearmind Medicineがアルコール使用障害治療薬CMND-100のFDA承認第I/IIa相臨床試験において、現在の第3群患者の治療を継続。
0
0
0